Octave Bioscience, Inc., a commercial-stage precision neurology company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson’s disease, ...
Mavenclad may help manage coexisting autoimmune diseases alongside MS, potentially reducing the need for extra drugs.
Everyday Health on MSN
4 myths about multiple sclerosis and diet
Although certain diets are sometimes touted as solutions for multiple sclerosis, they often lack evidence to support their ...
Certain gut bacteria may influence the odds of developing MS, in part by altering the activity of specific immune cells, ...
The Anne Arundel County resident recently announced his retirement because of complications surrounding a multiple sclerosis ...
A Norwegian-Swedish clinical trial published in the New England Journal of Medicine demonstrates that rituximab, a low-cost B ...
Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...
Flow Space on MSN
Jamie-Lynn Sigler on living with multiple sclerosis
Sponsored by Novartis Jamie Lynn Sigler opens up about self-advocacy, finding her treatment plan and why your voice should be ...
Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results